• MorphoSys Appoints New Head of Research Antibody Business

News & Views

MorphoSys Appoints New Head of Research Antibody Business

Mar 17 2009

MorphoSys AG (Martinsreid/Munich) has appointed Dieter Feger to head its AbD Serotec business for research and diagnostic antibodies. He joins the company from Abbott Diagnostics, where he was of Marketing Director - Global Marketing for the past four years most recently with
responsibility for Infectious Diseases, Abbott Diagnostics’ biggest reagent franchise. Prior to that, he spent 18 years with Abbott in Europe, in a variety of roles before moving to the US. He replaces Dieter Lingelbach who has left MorphoSys to pursue new opportunities.

"I am delighted to welcome Dieter Feger to the management team of MorphoSys. He brings deep experience from his work at Abbott Diagnostics, one of the industry’s leading companies, that will assist AbD Serotec to seek new growth opportunities and to expand its footprint in the diagnostics industry," commented Dr Simon Moroney, Chief Executive Officer of MorphoSys AG. "I would like to thank Dieter Lingelbach for his
invaluable contribution to establishing AbD Serotec as a leading supplier of research antibodies and wish him well in the future."

Digital Edition

ILM 49.5 July

July 2024

Chromatography Articles - Understanding PFAS: Analysis and Implications Mass Spectrometry & Spectroscopy Articles - MS detection of Alzheimer’s blood-based biomarkers LIMS - Essent...

View all digital editions


ADLM 2024

Jul 28 2024 San Diego, CA USA

InaLab 2024

Jul 30 2024 Jakarta, Indonesia


Jul 31 2024 Chengdu, China

ACS National Meeting - Fall 2024

Aug 18 2024 Denver, CO, USA


Aug 25 2024 Copenhagen, Denmark

View all events